For your eyes only: Harnessing human embryonic stem cell-derived retinal pigment epithelial cells to improve impaired vision

Genes and Diseases - Tập 2 - Trang 293-294 - 2015
Jim Hu1, Tong-Chuan He2, Fei Li3
1Department of Pathology and Laboratory Medicine, The Hospital for Sick Children, University of Toronto, Toronto, Ontario M5G 0A4, Canada
2Molecular Oncology Laboratory, The University of Chicago Medical Center, Chicago, IL 60637, USA
3The Editorial Office of Genes & Diseases, Chongqing, 400046, China

Tài liệu tham khảo

Kokotas, 2011, Age-related macular degeneration: genetic and clinical findings, Clin Chem Lab Med CCLM/FESCC, 49, 601, 10.1515/CCLM.2011.091 Westeneng-van Haaften, 2012, Clinical and genetic characteristics of late-onset Stargardt's disease, Ophthalmology, 119, 1199, 10.1016/j.ophtha.2012.01.005 Schwartz, 2015, Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies, Lancet, 385, 509, 10.1016/S0140-6736(14)61376-3 Song, 2015, Treatment of macular degeneration using embryonic stem cell-derived retinal pigment epithelium: preliminary results in Asian patients, Stem Cell Rep, 4, 860, 10.1016/j.stemcr.2015.04.005 Zamiri, 2007, Immunosuppressive properties of the pigmented epithelial cells and the subretinal space, Chem Immunol Allergy, 92, 86, 10.1159/000099259